Bilateral breast carcinoma: Risk factors and outcomes for patients with synchronous and metachronous disease

Cancer

Volumn 88, Issue 12, 2000, Pages 2739-2750

  Heron, Dwight E ^a,b   Komarnicky, Lydia T ^a   Hyslop, Terry ^b   Schwartz, Gordon F ^b   Mansfield, Carl M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bilateral; Breast carcinoma; Metachronous; Synchronous

Indexed keywords

ADULT; AGED; ARTICLE; BILATERAL CANCER; BREAST CARCINOMA; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0034660305     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000615)88:12<2739::AID-CNCR12>3.0.CO;2-J     Document Type: Article

References (52)

1. Al-Jurf AS, Jochimsen PR, Urdantea LF, Scott DH. Factors influencing survival in bilateral breast cancer. J Surg Oncol 1961;16:343.
2. Pomerantz RA, Murand T, Hines JR. Bilateral breast cancer. Am Surg 1989;55:441.
3. Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier JM. Contralateral breast cancer and other second malignancies in patients treated by breast conserving therapy with radiation. Int J Radiat Oncol Biol Phys 1988;15:277-84.
4. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:99-112.
5. McCredie JA, Inch WR, Anderson M. Consecutive primary carcinomas of the breast. Cancer 1975;35:1472-7.
6. Michowitz M, Noy S, Lazebnik N, Aladjem D. Bilateral breast cancer. J Surg Oncol 1985;30:109.
7. Beller FK, Nienhaus H, Niedner W, Holzgreve W. Bilateral breast cancer: the frequency of undiagnosed cancers. Am J Obstet Gynecol 1986;155:247-55.
8. Bernstein IL, Thompson WD, Risch N, Holford TR. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 1992;136:925-36.
9. Fracchia AA, Robinson D, Legaspi A, Greenall MJ, Kinne DW, Groshen S. Survival in bilateral breast cancer. Cancer 1991;55:1414-21.
10. Go RCP, King MC, Bailey-Wilson J. Genetic epidemiology of breast cancers and association of cancer in high-risk families: segregation analysis. J Nat Cancer Inst 1983;71:455-61.
11. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1989;131:961-72.
12. Schwartz AG, King MC, Belle SH. Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 1985;75:665-8.
13. Malone KE, Daling JR, Weiss NS, McKnight B, White E, Voigt LF. Family history of young women with invasive breast carcinoma. Cancer 1996;78:1417-25.
14. Clovet KT. Bilateral breast carcinoma after radiation for Hodgkin's disease. South Med J 1995;88:239-42.
15. Carey RW, Linggood RM, Wood W. Breast cancer developing in four women cured of Hodgkin's disease. Cancer 1984;54: 2234-6.
16. Yaholam J, Petrek JA, Biddinger PW. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis if 45 events in 37 patients. J Clin Oncol 1992; 10:1674-81.
17. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993;85: 25-31.
18. Miller AB, Howe GR, Sherman GJ. Mortality from breast cancer after irradiation during fluoroscopic examination in patients treated for tuberculosis. N Engl J Med 1989;321: 1285-9.
19. MacKenzie I. Breast cancer following multiple flouroscopies. Br J Cancer 1965;19:1-18.
20. Shore RE, Hempelman LH, Kowaluk E. Breast neoplasms in women treated with X-rays for acute post-partum mastitis. J Natl Cancer Inst 1977;59:813-22.
21. Mansfield CM, Komarnicky LT, Schwartz GF, Rosenberg AL, Krishnan L, Jewell WR, et al. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 1995;75:2328-36.
22. Schmidt-Ullrich RK, Wazer DE, DiPetrillo T, Marchant DJ, Smith TJ, Safaii H, et al. Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant. Int J Radiat Oncol Biol Phys 1993; 27:545-52.
23. Krishnan L, Jewell WH, Mansfield CM, Reddy EK, Thomas JH, Krishnan EC. Early-stage breast cancer: local control after conservative surgery and radiation therapy with immediate interstitial boost. Radiology 1993;187:95-8.
24. Mansfield CM, Krishnan L, Komarnicky LT, Ayyangar KM, Kramer CA. A review of the role of radiation therapy in the treatment of patients with breast cancer. Semin Oncol 1991; 18:525-35.
25. Fisher B, Bauer M, Margolese R. Five-year results of a randomized clinical trial comparing mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985;312:665.
26. Fisher B, Redmond C. Lumpectomy for breast cancer: an update of the NSABP experience. J Natl Cancer Inst Monogr 1992;11:7.
27. American Joint Committee on Cancer. Breast. In: Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, editors. AJCC cancer staging manual, 5 ed. Philadelphia: J.B. Lippincott, 1997:171-80.
28. Chaudary MA, Millis RR, Hoskins EO, Halder M, Bulbrook RD, Cuzick J, et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 1984;71:711-4.
29. Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG. Second primary cancers of the breast: incidence and risk factors. Br J Cancer 1984;49:79-85.
30. Adami Ho, Bergostrom R, Hansen J. Age at first primary as a determinant of the incidence of bilateral breast cancer: cumulative and relative risk in a population-based case-control study. Cancer 1985;55:643-7.
31. Lazovitch D, White E, Thomas DB, Moe RE. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991;266: 3433-8.
32. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992; 326:1097-101.
33. Nattinger AB, Gottlieb MS, Vwum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 1992;326:1102-7.
34. Bodian C, Haagensen CD. Bilateral carcinoma of the breast. In: Haagensen CD, editor. Diseases of the breast, 3rd ed. Philadelphia: WB Saunders, 1986:440-61.
35. Bernstein JL, Thompson WD, Risch N, Holford T. The genetic epidemiology of second primary breast cancer. Am J Epidemiol 1992;136:937-48.
36. Fisher ER, Fisher B, Sass R, Wickerham L, NSABP Investigators. Pathologic findings from the National Surgical Breast Project (protocol No. 4). XI. Bilateral breast cancer. Cancer 1984;54:3002-11.
37. Kim DH, Haffty BG. Bilateral breast carcinoma: results with breast conservation therapy and a comparison with bilateral mastectomy. Proc Int J Radiat Oncol Biol Pliys 1996;36:273.
38. Solin LJ, Fowble BL, Schultz DJ, Goodman RL. Bilateral breast carcinoma treated with definitive irradiation. Int J Radiat Biol Phys 1989;17:263-71.
39. Fung MC, Schultz DJ, Solin LJ. Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 1997;38:959-67.
40. Lee MM, Chen LM, Heimann R, Powers C, Weichselbaum RR. Efficacy of breast conservation therapy in early stage bilateral breast cancer. Proc Int J Radiat Oncol Biol Phys 1996;36:281.
41. de la Rochefordiere D, Asselain B, Scholl S, Campana F, Ucla L, Vilcuq JR, et al. Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 1994;30:35-41.
42. Fischer B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Nat Cancer Inst 1998; 90:1371-88.
43. Gustafsson A, Tartter PI, Brower ST, Lesnick G. Prognosis of patients with bilateral carcinoma of the breast. J Am Coll Surg 1994;178:111-6.
44. Holmberg L, Adami HO, Bergström R, Sandström A, Lindgren A. Prognosis in bilateral breast cancer: effect of time interval between first and second primary tumors. J Cancer 1988;58:191-4.
45. Kinoshita T, Ueda M, Enomoto K, Ikeda T, Kikuchi K, Ishii S, et al. Comparison of p53 abnormalities in bilateral and unilateral breast cancer. Cancer 1995;76:2504-9.
46. Ackerman J, Baunoch DA, Gimotty P, George J, Lane MA, Dawson PJ. The role of p53 mutations in bilateral breast carcinoma. Mod Path 1995;8:244-8.
47. Davidoff AM, Herdon JE, Glover NS, Kerns BJ, Pence JC, lglehart JD, et al. Relationship between p53 over-expression and established prognostic factors in breast cancer. Surgery 1991;110:259.
48. Thor AD, Moore DH, Edgerton SM, Kawasaki ES, Reihaus E, Lynch HT, et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845.
49. Green MH. Genetic of breast cancer. Mayo Clin Proc 1997; 72:54-65.
50. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Eng J Med 1997;336:1409-15.
51. Krainer M, Silva-Arrieta S, Fitzgerald MG, Shimada A, Ishioka C, Kanamaru R, et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Eng J Med 1997;336:1416-21.
52. Kopelson G, Munzenrider JE, Doppke K, Wang CC. Bilateral breast cancer: radiation therapy results and technical considerations. Int J Radiat Oncol Biol Phys 1981;7:335-41.